Table 1.
Clinicopathological features of colorectal cancer patients included in ex vivo multiparametric analysis
| All tumors (n = 35) | MSI tumors (n = 8, 22.9%) | MSS tumors (n = 27, 77.1%) | |
|---|---|---|---|
| Age | |||
| (mean (range)) | 68.8 (36–88) | 74.9 (42–88) | 67.0 (36–82) |
| Gender | |||
| Women (N (%)) | 15 (42.9) | 4 (50.0) | 11 (40.7) |
| Men (N (%)) | 20 (57.1) | 4 (50.0) | 16 (59.3) |
| Tumor location | |||
| Right (N (%)) | 15 (42.9) | 7 (85.7) | 8 (29.6) |
| Left (N (%)) | 15 (42.9) | 0 (0.0) | 15 (55.6) |
| Rectum (N (%)) | 5 (14.2) | 1 (14.3) | 4 (14.8) |
| Histological subtypes | |||
| Adenocarcinoma not otherwise specified (N (%)) | 29 (82.9) | 6 (75.0) | 23 (85.2) |
| Mucinous adenocarcinoma (N (%)) | 6 (17.1) | 2 (25.0) | 4 (14.8) |
| CMS classification | |||
| CMS1 (N (%)) | 5 (14.3) | 4 (50.0) | 1 (3.7) |
| CMS2 (N (%)) | 11 (31.3) | 0 (0.0) | 11 (40.7) |
| CMS3 (N (%)) | 5 (14.3) | 1 (12.5) | 4 (14.8) |
| CMS4 (N (%)) | 3 (8.6) | 0 (0.0) | 3 (11.1) |
| Unclassified (N (%)) | 3 (8.6) | 1 (12.5) | 2 (7.4) |
| NA (N (%)) | 8 (22.9) | 2 (25.0) | 6 (22.3) |
| UICC stage | |||
| I (N (%)) | 4 (11.4) | 0 (0.0) | 4 (14.8) |
| II (N (%)) | 17 (48.6) | 7 (85.7) | 10 (37.0) |
| III (N (%)) | 13 (37.1) | 0 (0.0) | 13 (48.1) |
| IV (N (%)) | 1 (2.9) | 1 (14.3) | 0 (0.0) |